02 December,2020 10:29 AM IST | Chennai | Agencies
A health worker takes a swab sample from a woman at a temporary camp setup inside a public parking area in Mumbai. Pic/AFP
Vaccine development company Serum Institute, India on Tuesday said the Covidshield vaccine will not be released for mass use unless it is proven immunogenic, and safe. The company also said the serious adverse event (SAE) that happened to a city-based volunteer though unfortunate was in no way induced by the vaccine.
Serum Institute, which had earlier said it would claim over '100 crore damage from the volunteer for damaging its reputation, said it was sympathetic with the volunteer's medical condition and the incident is highly unfortunate.
"However, we would like to clarify that all the requisite regulatory and ethical processes and guidelines were followed diligently and strictly," the company said. According to Serum Institute, the concerned authorities were informed and the principal investigator, Data Safety Monitoring Board (DSMB) and the Ethics Committee independently cleared and reckoned it as a non-related issue to the vaccine trial.
"Post which we submitted all the reports and data related to the incident to the Drug Controller General of India. It is only after we cleared all the required processes that we continued with the trials," the company said.
ALSO READ
Lasha Shavdatuashvili urges more competitions to develop judo in India
Philippine showdown: President says he'll fight vice president's plot to have him killed
India reclaim top spot in WTC points table after trouncing Australia in Perth Test
President Murmu to lead celebrations to mark 75 years of Constitution
Two groups clash in Mehkar town of Buldhana district
Gujarat govt slashes cost of RT-PCR tests
Following examples of Rajasthan and Delhi, the Gujarat government on Tuesday slashed the cost of RT-PCR tests for Coronavirus at private laboratories from '1,500 to '800 each. Deputy Chief Minister Nitin Patel said the decision will be effective from Tuesday itself. He said that due to the prevailing Coronavirus situation in the state, a core group meeting headed by Chief Minister Vijay Rupani decided to slash the cost of RT-PCR tests in private laboratories.
Nov sees 30% decline in new cases, deaths
India's COVID-19 caseload rose to 94.96 lakh with November registering over 30 per cent decline in both new deaths and cases as compared to October, while total recoveries surged to 89,29,084, according to the Union Health Ministry's data updated on Tuesday.
Eastern Railway services to resume
As many as 54 non-suburban passenger trains will resume operations in the Eastern Railway section (ER) from December 2. The services were suspended in the last week of March this year owing to the ongoing COVID-19 pandemic. According to railway officials, at least 30 trains will run in Howrah division and 22 trains in Asansol division while two trains will run in Malda division.
Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.
Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
